| Title | Author(s) | Year | View Count |
 | PTK787/ZK22258 attenuates stellate cell activation and hepatic fibrosis in vivo by inhibiting VEGF signaling | Liu, Y; Lui, ELH; Friedman, SL; Li, L; Ye, T; Chen, Y; Poon, RT; Wo, J; Kok, TW; Fan, ST | 2009 | 267 |
| Blockage of epidermal growth factor receptor by quinazoline tyrosine kinase inhibitors suppresses growth of human hepatocellular carcinoma | Liu, Y; Poon, RTP; Shao, W; Sun, X; Chen, H; Kok, TW; Fan, ST | 2007 | 170 |
 | Blockade of chemokine (C-X-C motif) receptor 4 for the treatment of hepatocellular carcinoma metastasis (Poster Presentation) | Kok, TW; Yang, Z; Poon, RTP | 2007 | 68 |
| Blockade of VEGF/VEGFR pathway enhances chemo-sensitivity in hepatocellular carcinoma (Poster Presentation) | Yang, Z; Kok, TW; Or, YYY; Ng, NP; Tam, KH; Fan, ST; Poon, RTP | 2007 | 111 |
| A study of the effect of vascular endothelial growth factor tyrosine kinase inhibitor PTK 787/ZK222584 on liver fibrosis (Abstract) | Liu, Y; Poon, RTP; Qian, XM; Li, L; Lau, CPY; Chen, YJ; Kok, TW; Fan, ST | 2006 | 75 |
| Involvement of protein kinase C and E2F-5 in euxanthone-induced neurite differentiation of neuroblastoma | Ha, WY; Wu, PK; Kok, TW; Leung, KW; Mak, NK; Yue, PYK; Ngai, SM; Tsai, SN; Wong, RNS | 2006 | 34 |
| Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584 | Liu, Y; Poon, RT; Li, Q; Kok, TW; Lau, C; Fan, ST | 2005 | 140 |
|
